About the Study
We are currently recruiting participants ages 40 and older with moderate to severe plaque psoriasis. Eligible participants must have at least one cardiovascular risk factor or a family history of heart disease. This study provides an opportunity to access potential new treatments while contributing to important psoriasis and heart health research.